EP1786957A1 - Fibres antimicrobiennes et leur production - Google Patents

Fibres antimicrobiennes et leur production

Info

Publication number
EP1786957A1
EP1786957A1 EP05768044A EP05768044A EP1786957A1 EP 1786957 A1 EP1786957 A1 EP 1786957A1 EP 05768044 A EP05768044 A EP 05768044A EP 05768044 A EP05768044 A EP 05768044A EP 1786957 A1 EP1786957 A1 EP 1786957A1
Authority
EP
European Patent Office
Prior art keywords
microbial
fibres
lyocell fibres
silver
support material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05768044A
Other languages
German (de)
English (en)
Inventor
Hiran The Orchards Apt. 20 VEGAD
Malcolm Hayhurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lenzing AG
Original Assignee
Lenzing AG
Chemiefaser Lenzing AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lenzing AG, Chemiefaser Lenzing AG filed Critical Lenzing AG
Publication of EP1786957A1 publication Critical patent/EP1786957A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F2/00—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties
    • D01F1/103—Agents inhibiting growth of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913—Rod, strand, filament or fiber
    • Y10T428/2933—Coated or with bond, impregnation or core
    • Y10T428/294—Coated or with bond, impregnation or core including metal or compound thereof [excluding glass, ceramic and asbestos]

Definitions

  • the present invention relates to anti-microbial lyocell fibres which can impart qualities of freshness and hygiene to fabrics made from the fibres. It also relates to a process for making such fibres.
  • Another way of achieving this is to apply anti-microbial agents to the fabric, for example as a finishing treatment.
  • Another way, offering greater commercial flexibility, is to provide fibres that are already anti-microbial, by virtue of having an anti-microbial agent applied to or incorporated into the fibres.
  • Many organic anti-microbial agents have been used or proposed for use on fibres, including triclosan, biguanides, phenols and derivatives, isothiazolones, quaternary ammonium salts, tri-butyl tin oxide, haloamines and alcohols.
  • triclosan which has been used as a fibre finish and fabric finish for both natural and man-made fibres and has also been incorporated into man-made fibres such as regenerated cellulose fibres and acrylic fibres by inclusion in the spinning dope.
  • Inorganic anti-microbial agents have also been used, and these are predominantly compounds in which a metal ion such as silver is supported on an inert matrix.
  • An example of such an agent is silver zeolite.
  • Lyocell fibres are produced by extrusion of a solution of cellulose through a spinning jet into a coagulation bath by a process known as solvent spinning. They are therefore alternatively known as solvent-spun cellulose fibres.
  • Lyocell fibres are distinguished from regenerated cellulose fibres, such as viscose fibres, which are produced by forming the cellulose into a soluble chemical derivative and then extruding a solution of this derivative into a bath, which regenerates the extrudate as cellulose fibres.
  • Another process of this type is described in EP-A- 0 905 289 and involves adding to a solution of cellulose in an amine oxide solvent a slurry of a silver-based anti-bacterial agent and a magnetised mineral ore powder.
  • the selected silver-based anti-bacterial agents include silver zeolites, silver zirconium phosphates and silver calcium phosphates. These silver compounds produce unacceptable colour staining on the fibres.
  • a stabiliser particularly propyl gallate.
  • the purpose of this stabiliser is to sequester free radicals, particularly metal ions, which can catalyse exothermic reactions in the system, leading to uncontrolled explosions. Use of such a stabiliser is, therefore, believed to be universal in practice.
  • the concern with adding silver compounds is twofold: firstly, that the stabiliser will sequester the silver, deplete it as residual anti-microbial agent and cause staining, and, secondly, that the silver compound will use up the stabiliser and leave insufficient in the system to protect against exothermic reactions.
  • WO 03/018166 and WO 2004/022822 also relate to cellulosic materials which may contain silver.
  • Anti-microbial compositions disclosed and claimed in EP-A-0251783, the contents of which are hereby incorporated into this specification, comprise an anti-microbial silver compound deposited on a support comprising a physiologically inert oxidic synthetic material in particulate form and having an extended surface area. These compositions were developed by the proprietor of that patent, Johnson Matthey pic, for incorporation into coating or impregnating formulations for medical or other appliances or for topical application to bandages and dressings. The present invention is concerned with the use of anti- microbial compositions of this type.
  • the present invention provides anti-microbial lyocell fibres incorporating an anti-microbial composition which includes a silver compound held on a support material, characterized in that the anti-microbial composition comprises a silver compound deposited on a support material in the form of porous particles having an extended surface area and comprising an oxidic material which is essentially insoluble in water and incapable of forming hydrates.
  • the support material in the form of the porous particles, is oxidic and may comprise an oxide or a hydroxide or a complex oxy-anion species such as phosphate or sulphate. It is essentially insoluble in water and also stable in water, in the sense of being incapable of forming a hydrate but being able to adsorb water to form an associated aqueous species.
  • Oxidic materials which may be used for the support material, used in the form of porous particles include oxides of titanium, magnesium, aluminium, silicon, cerium, zirconium, hafnium, niobium and tantalum, calcium hydroxyapatite (a phosphate), and barium sulphate, all to the extent of being insoluble and stable in water as specified. Titanium dioxide is a preferred oxidic support material and is stable to water in its anatase, rutile and brookite crystalline forms; hydrated or hydratable oxides of titanium are not suitable for use in this invention.
  • the particle size of the porous particles which comprise the oxidic support material is preferably as small as possible commensurate with achieving the desired anti-microbial effect.
  • the average particle diameter is less than about 25 microns and more preferably it is in the range 0.5 to 10 microns.
  • the particles may have a highly open structure, for example generally spherical clusters of crystallites having a large physical voidage.
  • the surface area of the particles may extend from about 1 or 2 square metres per gram up to about 240 square metres per gram or more, but it is preferably in the range 5 to 100 square metres per gram.
  • the silver compound deposited on the porous particles which comprise the oxidic support material is preferably one which has a low solubility in water and aqueous media, for example a solubility below 0.01 gram per litre of water at 20 0 C, and in which the silver is present as an ionic species. It may be present at a level of about 1 to about 75 per cent by weight of the oxidic support material, preferably 10 to 60 per cent by weight.
  • a preferred silver compound is silver chloride.
  • Silver phosphate is also suitable.
  • a preferred anti-microbial composition comprises silver chloride deposited on titanium dioxide particles, with appropriate concentrations of the silver chloride being, for example, about 15 to about 25 per cent, such as about 15 per cent, about 20 per cent or about 25 per cent, by weight based on the weight of the titanium dioxide particles.
  • the silver compound may be deposited on the porous support particles by controlled nucleation and growth so that the silver compound is largely contained within the pores of the particles and the particle size distribution is maintained by avoiding any coalescence.
  • the anti-microbial composition may be used in relatively low concentrations in the lyocell fibres of the invention and still produce effective anti-microbial properties.
  • concentrations of the anti-microbial composition in the fibres below about 1 per cent by weight owe (on weight of cellulose).
  • concentrations of the anti-microbial composition in the fibres below about 1 per cent by weight owe (on weight of cellulose).
  • concentrations of the anti-microbial composition in the fibres below about 1 per cent by weight owe (on weight of cellulose).
  • concentrations of the anti-microbial composition in the fibres below about 1 per cent by weight owe (on weight of cellulose).
  • concentrations of that particular anti-microbial composition have been used satisfactorily, and it is preferred to use a level of concentration below about 0.1 per cent by weight owe.
  • good results have been achieved using a concentration of 0.0125 per cent by weight owe, which is a remarkably low concentration.
  • the fibres can, in addition to the silver-containing anti-microbial composition, contain a matting agent, for example Ti 02, to produce fibres which are dull or matt. Matting agent concentrations of from 0.5 to 2.5 per cent by weight Ti O2 or equivalent can be used. Such agents are especially useful for non-woven products.
  • a matting agent for example Ti 02
  • Matting agent concentrations of from 0.5 to 2.5 per cent by weight Ti O2 or equivalent can be used. Such agents are especially useful for non-woven products.
  • the silver-containing fibres of the invention may be used in textiles for hospital use (e.g. bedding, towels, gowns, uniforms), socks and underwear, military textiles (combat suits), sportswear, interlinings for garments and home textiles (mattresses and upholstery), fibre fill for duvets pillows outdoor jackets and ski suits, blankets towels and towelling, carpets and mats, and conveyor belts for frozen food, and for non-wovens such as wound dressings (cosmetic pads, filters, wet wipes, wipes, baby wipes, medical devices, incontinence products, water filters, plaster cast linings, interlinings, roller towels, shoe linings, dry wipes and floor tiles .
  • wound dressings cosmetic pads, filters, wet wipes, wipes, baby wipes, medical devices, incontinence products, water filters, plaster cast linings, interlinings, roller towels, shoe linings, dry wipes and floor tiles .
  • the lyocell fibres may be carboxymethylated, partially or even completely.
  • the lyocell fibres of the invention possess excellent anti-microbial properties, and these properties are durable to conventional scouring, washing and dyeing procedures for lyocell fibres and fabrics.
  • the fibres retain their usual good mechanical properties and are not spoiled by colour staining or by permanent yellowing or greying. To the extent that there is a slight fall in whiteness of the fibres, this is only temporary and is removed by the normal washing and scouring processes to which the fibres are subjected in manufacture.
  • the properties of the lyocell fibres of the invention are both excellent and unpredicted.
  • the invention includes a process for making anti-microbial lyocell fibres in which cellulose is dissolved in a solvent of aqueous amine oxide to form a spinning solution which is extruded through a spinning jet into a coagulation bath to produce lyocell fibres, and an anti-microbial composition is incorporated into the fibres, characterized in that the anti-microbial composition is added to the fibre spinning solution or to a precursor or ingredient of that solution and comprises a silver compound deposited on a support material in the form of porous particles having an extended surface area and comprising an oxidic material which is essentially insoluble in water and incapable of forming hydrates.
  • the anti-microbial composition may be added to the spinning solution or to an ingredient of that solution, for example the amine oxide solvent.
  • a precursor of the cellulose solution comprising a pasty pre- mix of the cellulose pulp and the amine oxide solvent.
  • One method of forming the solution of cellulose in an amine oxide solvent such as tertiary amine N- oxide, for example N-methylmorpholine N-oxide is to form a pre-mix of cellulose and aqueous amine oxide solvent incorporating an excess of water over the optimum required for solution to take place.
  • the pre-mix which is a paste or dough, is then subjected to an evaporation process, for example in a thin-film evaporator, to remove the excess water and form a solution of the cellulose.
  • the anti-microbial composition which has been added to the pre-mix, is effectively dispersed throughout this resulting cellulose solution.
  • the anti-microbial composition may be added to the pre-mix itself or to an ingredient of the pre-mix, preferably the former.
  • the anti-microbial composition may be added in the form of a dispersion in a liquid, for example in water, or in dry powder form. It may be added to the vessel in which the pre-mix is made but, preferably, is added to the pre-mix in the hopper feeding the pre-mix to the thin film evaporator which forms the spinning solution. Addition may be made using injection equipment such as is used to add matting agents such as titanium dioxide. In fact, the anti-microbial composition and the matting grade of titanium dioxide may be added together.
  • the process of the invention may be carried out without any significant processing problems.
  • the sequestering stabiliser which is preferably propyl gallate, appears to remove insignificant amounts of the silver compound from the anti-microbial composition.
  • the oxidic support material appears to stabilise the silver compound against the activity of the propyl gallate during the manufacturing process.
  • the corollary of this is that the propyl gallate does not become excessively used up by reacting with the silver compound and instead remains in the system to scavenge radicals which could otherwise trigger explosive exothermic reactions. Propyl gallate does not leave the spinning system with the fibres and so cannot affect the anti-microbial composition once it is incorporated into the fibres.
  • the anti-microbial composition used for the purposes of both of these Examples was a product, JMAC-PG, supplied by AddMaster (UK) Ltd. and comprised a dry powder of porous titanium dioxide particles on which 20 percent by weight of silver chloride had been deposited.
  • the particle diameters were in the range 0.5 to 2 microns, with the majority of particles being sub-micron in diameter.
  • the fibre-making process was based on a commercial process for making lyocell fibres of 1.4 dtex by spinning a solution of cellulose in a solvent of aqueous N- methylmorpholine N-oxide through a spinning jet into an aqueous coagulating bath to form fibres.
  • the spinning solution was made by a process in which cellulose pulp and the solvent of aqueous N-methylmorpholine N-oxide were fed into a mixing vessel and mixed to form a paste or dough, known as the pre-mix.
  • the solvent contained excess water over the optimum required for the cellulose to go into solution, in order to promote efficient wetting and mixing of the cellulose with the solvent.
  • This excess water was then evaporated from the pasty pre-mix by passing the pre-mix through a type of thin-film evaporator called a Filmtruder (trademark of BUSS AG) to form the spinning solution.
  • the JMAC powder was dispersed in water and added as a dispersion to the pre- mix at the hopper feeding the pre-mix into the Filmtruder.
  • Example 1 Two different concentrations of JMAC were used in two different production runs.
  • the first (Example 1) was a concentration of 125 ppm (parts per million) by weight owe, which is 0.0125 per cent by weight owe.
  • the second (Example 2) was a concentration of 250 ppm by weight owe, which is 0.0250 per cent by weight owe.
  • the JMAC anti-microbial composition was evenly distributed in the spinning solution formed by the Filmtruder and so was evenly distributed in the spun lyocell fibres.
  • the JMAC composition did not adversely affect the process of making the spinning solution or of spinning the fibres, and it was not itself adversely affected by these processes.
  • Samples of spun yarns of count 20 Tex were made from the respective fibres of Examples 1 and 2 and of the Control, the fibres having been cut to 38mm staple length. These yarns were used to weave respective greige fabrics in an interlock construction, each of basis weight 200 gms per square metre.
  • the scoured fabrics produced from the fibres of Examples 1& 2 were tested for colour whiteness against the scoured Control fabric produced from the standard lyocell Control fibres. Testing was carried out using a Minolta Spectrophotometer CM-3300d and produced a CIE (Commission Internationale d'Eclairage) whiteness index of 70.7 for the fabric of Example 1 and a CIE whiteness index of 67.1 for the fabric of Example 2, as against a CIE whiteness index of 73.7 for the Control fabric. This shows that the anti-microbial composition JMAC has no significant effect on fibre colour, particularly at the lower concentration of 125 ppm used in Example 1.
  • CIE Commission Internationale d'Eclairage
  • the fabrics were re-tested after controlled exposure to a xenon lamp, which mimicked 4 weeks' outdoor natural light exposure, and, again, there was little difference in colour between the fabrics.
  • This test was carried out using a Staphylococcus aureus bacterium.
  • ASTM E2149-01 Quantitative Dynamic Shake Flask Test This is a test of the American Society for Testing and Materials, which measure the anti-microbial activity of both leaching and non-leaching anti-microbial materials under dynamic contact conditions. Evaluation is based upon the calculated percentage reduction in bacteria from counts taken at various times and expressed as calculated percentage reduction and also as log reduction versus a no-sample control.
  • the fibres of each of Examples 1&2 were tested alongside Control fibres, and also against a control in which no fibres were used, i.e. a no-sample control.
  • Three different bacteria were tested: the Staphylococcus aureus bacterium; the Klebsiella pneumoniae bacterium; and the methic ⁇ llin-resistant Staphylococcus aureus bacterium [MRSA).
  • the results shown in Table 2 confirm strong anti-microbial activity against all three species of bacterium for the fibres of both Examples 1 and 2. Furthermore, as shown, this strong activity is sustained after the scouring, dyeing and detergent washing treatments given and is considered durable.
  • the anti-microbial results obtained for the fibres of Example 2 are, generally, no better than those obtained for the fibres of Example 1. Therefore, considerations of the better whiteness obtained with the fibres of Example 1 and the lower cost of using half the concentration of the JMAC anti-microbial composition, compared with the fibres of Example 2, indicate that a concentration of 125 ppm by weight owe of the JMAC composition is to be preferred to higher amounts.

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Textile Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Artificial Filaments (AREA)

Abstract

L’invention porte sur des fibres de cellules dissoutes antimicrobiennes comportant une composition antimicrobienne contenant un composé d’argent déposé sur un matériau support sous forme de particules poreuses d’une superficie étendue et englobant un matériau oxyde essentiellement insoluble dans l’eau et incapable de former des hydrates. Une composition préférée est le chlorure d’argent déposé sur des particules de dioxyde de titane. L’effet antimicrobien est durable au traitement et les fibres ne sont pas décolorées de manière adverse. On peut utiliser de faibles concentrations de la composition antimicrobienne inférieures à 0,1 pour cent en poids de cellulose. Dans le processus de fabrication des fibres, on ajoute de préférence la composition antimicrobienne au prémélange pâteux de la solution de centrifugation.
EP05768044A 2004-08-05 2005-08-04 Fibres antimicrobiennes et leur production Withdrawn EP1786957A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417477.7A GB0417477D0 (en) 2004-08-05 2004-08-05 Anti-microbial fibres
PCT/GB2005/003067 WO2006013378A1 (fr) 2004-08-05 2005-08-04 Fibres antimicrobiennes et leur production

Publications (1)

Publication Number Publication Date
EP1786957A1 true EP1786957A1 (fr) 2007-05-23

Family

ID=32982597

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05768044A Withdrawn EP1786957A1 (fr) 2004-08-05 2005-08-04 Fibres antimicrobiennes et leur production

Country Status (4)

Country Link
US (1) US20070243380A1 (fr)
EP (1) EP1786957A1 (fr)
GB (1) GB0417477D0 (fr)
WO (1) WO2006013378A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016481A1 (fr) * 2005-07-29 2007-02-08 Fiberweb, Inc. Dispositif de filtre multicomposé antimicrobien
AT503625B1 (de) 2006-04-28 2013-10-15 Chemiefaser Lenzing Ag Wasserstrahlverfestigtes produkt enthaltend cellulosische fasern
WO2007124522A1 (fr) * 2006-04-28 2007-11-08 Lenzing Aktiengesellschaft Produit non-tisse obtenu par fusion-soufflage
US20070269643A1 (en) * 2006-05-16 2007-11-22 James Calvin Bennett Antimicrobial pool filter
DE502007006156D1 (de) * 2006-07-21 2011-02-17 Smart Fiber Ag Reinigungstuch
DE102006056977B3 (de) * 2006-11-30 2008-05-08 Smart Fiber Ag Verwendung eines textilen mikrobioziden Speichers
AT508497A1 (de) * 2009-06-15 2011-01-15 Chemiefaser Lenzing Ag Schutzgewebe gegen ultraviolette strahlung auf grundlage künstlich hergestellter zellulosefasern
CN102597072A (zh) * 2009-09-30 2012-07-18 纺织和塑料研究协会图林根研究院 具有包覆材料和载体材料的模制品及其制备方法
TW201113409A (en) * 2009-10-06 2011-04-16 Ruentex Ind Ltd A yarn manufacturing method and a mixing yarn
GB2481824B (en) * 2010-07-07 2015-03-04 Innovia Films Ltd Producing cellulose shaped articles
US8641967B2 (en) 2011-02-23 2014-02-04 Applied Silver, Inc. Anti-microbial device
GB2511528A (en) 2013-03-06 2014-09-10 Speciality Fibres And Materials Ltd Absorbent materials
US10640403B2 (en) 2013-08-15 2020-05-05 Applied Silver, Inc. Antimicrobial batch dilution system
US11618696B2 (en) 2013-08-15 2023-04-04 Applied Silver, Inc. Antimicrobial batch dilution system
US10000881B2 (en) 2013-12-06 2018-06-19 Applied Silver, Inc. Method for antimicrobial fabric application
US20170050870A1 (en) 2015-08-21 2017-02-23 Applied Silver, Inc. Systems And Processes For Treating Textiles With An Antimicrobial Agent
EP3144376A1 (fr) * 2015-09-16 2017-03-22 Lenzing Aktiengesellschaft Utilisation d'une fibre lyocell
US20200123700A1 (en) 2017-03-01 2020-04-23 Applied Silver, Inc. Systems and processes for treating textiles with an antimicrobial agent
EP3385429A1 (fr) * 2017-04-03 2018-10-10 Lenzing Aktiengesellschaft Tissu de fibres de cellulose non tissé ayant des particules de diffusion de rayonnement connectés aux fibres
US10993859B2 (en) * 2017-12-14 2021-05-04 Matthew Aaron Halanski Cast saw protective system
WO2021237002A1 (fr) * 2020-05-21 2021-11-25 Piana Nonwovens, LLC. Non-tissé antimicrobien/antiviral et ses applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246221A (en) * 1979-03-02 1981-01-20 Akzona Incorporated Process for shaped cellulose article prepared from a solution containing cellulose dissolved in a tertiary amine N-oxide solvent
GB8616294D0 (en) * 1986-07-03 1986-08-13 Johnson Matthey Plc Antimicrobial compositions
EP0728855B1 (fr) * 1995-02-15 2000-09-13 Takeda Chemical Industries, Ltd. Fibres désodorisantes et procédé pour leur production
JP3051709B2 (ja) * 1997-09-30 2000-06-12 憲司 中村 抗菌性セルロ−ス繊維及びその製造方法
GB0026863D0 (en) * 2000-11-03 2000-12-20 Ssl Int Plc Polysaccharide fibres
DE10140772A1 (de) * 2001-08-20 2003-03-13 Zimmer Ag Verfahren zur Entfernung von Schwermetallen aus schwermetallhaltigen Medien unter Verwendung eines Lyocell-Formkörpers sowie Lyocell-Formkörper mit adsorbierten Schwermetallen und deren Verwendung
AT412728B (de) * 2002-09-03 2005-06-27 Chemiefaser Lenzing Ag Cellulosefaser
PL201205B1 (pl) * 2003-03-10 2009-03-31 Inst Wlokien Naturalnych Sposób wytwarzania modyfikowanych włókien celulozowych

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006013378A1 *

Also Published As

Publication number Publication date
GB0417477D0 (en) 2004-09-08
WO2006013378A1 (fr) 2006-02-09
US20070243380A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
US20070243380A1 (en) Anti-Microbial Fibres and Their Production
CA2329572C (fr) Composition de verre conferant des proprietes antibacteriennes, fibre antibacterienne, fil retors simple et chiffon antibacteriens
US5405644A (en) Process for producing antimicrobial fiber
EP2094903B1 (fr) Procédé pour apprêter des textiles avec des composants d'argent désensibilisés
CN100521943C (zh) 一种无机/有机纳米复合抗菌剂及其纤维制品应用
US7314570B2 (en) Method for removing heavy metals from media containing heavy metals by means of a Lyocell moulded body, cellulosic moulded body comprising absorbed heavy metals, and the use of the same
KR100441358B1 (ko) 키토산 함유 아크릴 섬유 및 그의 제조 방법
JP2003533613A (ja) 抗微生物剤移行基材およびその使用法
JP2014505801A (ja) 改良抗菌性能を有する繊維
CN108315860A (zh) 一种石墨烯抗菌毛巾的制备方法
JP2004513246A (ja) 耐洗濯性かつ非導電性の局所適用された金属に基づく仕上剤を有する糸および生地
DE102005031711A1 (de) Vor mikrobiellem Befall geschützte Textilien
JP4698386B2 (ja) 繊維用抗菌性付加処理液
GB2412083A (en) Making anti-microbial lyocell fibres containing silver and phosphate
WO1994015463A1 (fr) Compositions antimicrobiennes, et procede de preparation et d'utilisation de ces compositions
JP2001247334A (ja) 抗菌性付与用ガラス組成物及び抗菌性繊維
US6528162B1 (en) Acrylic synthetic fiber, use thereof, and process for producing acrylic synthetic fiber
JP3606638B2 (ja) 抗菌性を有する繊維製品およびその製造方法
JP2945264B2 (ja) 抗菌性繊維およびその製造方法
JP3792984B2 (ja) 繊維類の抗菌・抗カビ加工方法
EP3516106A1 (fr) Fibres cellulosiques antibactériennes régénérées et leur procédé de préparation
JPH02160915A (ja) 抗菌性アクリル系合成繊維及びその製造方法
CN115485430A (zh) 镁化合物的水分散液在纺织品功能整理中的应用
JP2000178870A (ja) 繊維製品の抗菌加工方法
CN107949630B (zh) 莱塞尔纤维的用途

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20070615

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071026